Revenue | ₹155.52Cr |
Net Profits | ₹20.77Cr |
Net Profit Margins | 13.36% |
Lincoln Pharmaceuticals Ltd’s revenue fell -1.24% since last year same period to ₹155.52Cr in the Q3 2024-2025. On a quarterly growth basis, Lincoln Pharmaceuticals Ltd has generated -9.15% fall in its revenue since last 3-months.
Lincoln Pharmaceuticals Ltd’s net profit fell -25.93% since last year same period to ₹20.77Cr in the Q3 2024-2025. On a quarterly growth basis, Lincoln Pharmaceuticals Ltd has generated -21.12% fall in its net profits since last 3-months.
Lincoln Pharmaceuticals Ltd’s net profit margin fell -25% since last year same period to 13.36% in the Q3 2024-2025. On a quarterly growth basis, Lincoln Pharmaceuticals Ltd has generated -13.17% fall in its net profit margins since last 3-months.
The revenue for Lincoln Pharmaceuticals Ltd in the Q3 results 2024 was ₹155.52Cr.
The net profit for Lincoln Pharmaceuticals Ltd in the Q3 results 2024 was ₹20.77Cr.
The net profit margin for Lincoln Pharmaceuticals Ltd in the Q3 results 2024 was 13.36%.
The revenue for Lincoln Pharmaceuticals Ltd in the Q3 results 2023 was ₹157.47Cr.
The net profit for Lincoln Pharmaceuticals Ltd in the Q3 results 2023 was ₹28.04Cr.
The net profit margin for Lincoln Pharmaceuticals Ltd in the Q3 results 2023 was 17.81%.